Financial Statements — CCEP
Balance Sheet
(in billions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 1.66 | 1.61 | 1.11 | 1.82 | 1.82 |
| Inventory | 1.81 | 1.91 | 1.71 | 1.41 | 1.24 |
| Total Current Assets | 8.08 | 7.52 | 7.46 | 6.98 | 6.01 |
| Goodwill | 4.54 | 4.79 | 4.48 | 4.67 | 4.58 |
| Total Non-current Assets | 23.71 | 24.58 | 22.34 | 23.38 | 23.16 |
| Total Assets | 31.79 | 32.10 | 29.80 | 30.35 | 29.17 |
| Total Current Liabilities | 9.69 | 8.88 | 8.77 | 7.42 | 6.62 |
| Total Non-current Liabilities | 13.59 | 14.21 | 13.27 | 15.16 | 15.75 |
| Total Liabilities | 23.28 | 23.09 | 22.04 | 22.57 | 22.38 |
| Retained Earnings | 8.95 | 8.72 | 8.01 | 7.14 | 6.45 |
| Total Stockholder Equity | 8.51 | 9.01 | 7.76 | 7.78 | 6.80 |
Income Statement
(in billions EUR) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 10.27 | 9.83 | 8.98 | 8.28 | 5.92 |
| Cost of Revenue* | 6.64 | 6.33 | 5.71 | 5.29 | 3.84 |
| Gross Profit | 3.64 | 3.50 | 3.27 | 2.99 | 2.08 |
| Total Operating Expenses* | 2.27 | 2.35 | 2.10 | 2.03 | 1.56 |
| Operating Income | 1.36 | 1.14 | 1.17 | 0.97 | 0.52 |
| Pretax Income | 1.26 | 1.05 | 1.10 | 0.90 | 0.46 |
| Tax Provision | 0.32 | 0.23 | 0.25 | 0.22 | 0.21 |
| Net Income | 0.94 | 0.81 | 0.85 | 0.68 | 0.25 |
| Basic EPS | 1.99 | 1.73 | 1.86 | 1.46 | 0.54 |
| Diluted EPS | 1.99 | 1.73 | 1.86 | 1.46 | 0.53 |
* Derived from reported values
Cash Flow Statement
(in billions EUR)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | 0.99 | 1.12 | 1.31 | 1.65 | 0.91 |
| Investing Cash Flow | (0.63) | (1.62) | (0.86) | (0.22) | (5.27) |
| Financing Cash Flow | (0.20) | 0.33 | (0.89) | (1.03) | 4.61 |
